Mayo Clinic has launched the first U.S. clinical research program using magnetic nanoparticle-mediated hyperthermia for ...
The FDA has approved nivolumab (Opdivo) plus AVD as first-line treatment for advanced classical Hodgkin lymphoma in patients ...
Phase 3 WU-KONG28 trial met its primary endpoint, showing that once-daily oral sunvozertinib significantly improved ...
TG Therapeutics secured $500 million in non-dilutive capital through a new credit facility, supporting the expansion of ...
Researchers developed a CAR-T manufacturing strategy using the cytokine fusion scaffold HCW9206 to generate longer-lasting ...
Phase 3 TALAPRO-3 results show that talazoparib plus enzalutamide significantly improves radiographic progression-free ...
Results from the phase 3 RECITE trial show that romiplostim significantly reduces chemotherapy-induced thrombocytopenia, ...
Vergent Bioscience has launched the Phase 3 VISUALIZE 2 trial evaluating abenacianine, a tumor-activated imaging agent ...
A Nature Cell Biology study shows that vitamin B2 metabolism helps cancer cells evade ferroptosis by stabilizing ferroptosis ...
The Phase 2 FOURLIGHT-1 trial shows that atirmociclib plus fulvestrant significantly improves progression-free survival in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results